Maxwell Dordevic

Maxwell Dordevic is currently the Chief Executive Officer at NeuroX1 Inc. and a Screening Committee member at CANCER FUND. Their previous roles include being an Editorial Board Member at the Journal Of Orthopaedics Study And Sports Medicine, a Principal at DITEC Ventures, the Chief Executive Officer at Veritas Innovation, and a Director of Market Research | International Sales at TRIDENT XI. Maxwell also has experience as a medical researcher and writer at Merck, a researcher at Celling Biosciences, and an Estimator at Lorentz Bruun Construction. They attended The University of Texas at Austin.